13F Filings/HHLR ADVISORS, LTD.

HHLR ADVISORS, LTD.

Hedge FundCIK0001762304LocationGRAND CAYMAN, Cayman Islands KY1-9006, United States

Long U.S. equity positions disclosed to the SEC on Form 13F-HR.

Latest filingQ2 2026Quarter ended30 Jun 2026Filed14 Aug 2026
Firm profile · Form ADV
SEC adviser registration

HHLR Advisors, Ltd. provides investment advice to privately-offered pooled investment vehicles and managed accounts. The firm generally focuses on publicly-listed or similarly liquid investment opportunities.Summarised from the firm’s Form ADV Part 2A brochure.

CRD
166112 · 802-128070
Portfolio Turnover
61%
Of book traded, QoQ
Positions
35
Long U.S. equities
Top 10 Concentration
86%
Of reported value
QoQ Change
$-840.7M
Value change
Assets under management
Form ADV RAUM · client mix · 13F over time
Regulatory AUM
$45.9B
Form ADV, as of Mar 2023
● 99% discretionary ($45.5B)
● 1% non-discretionary ($397M)
By client type
Pooled investment vehicles: $41.1B (89.7%) · 14 clients
Pooled investment vehicles
$41.1B · 90%
Pension & profit-sharing plans: $3.8B (8.2%) · 0 clientsSovereign wealth funds: $546M (1.2%) · 0 clientsOther: $397M (0.9%) · 0 clientsCorporations: $121K (0.0%) · 0 clients
13F AUM over time
$832M
Q2 ’26 · 13F AUM
▼ 65%
31 quarters
Reported Holdings
Q2 2026 · upgrade to Pro for past quarters
↗
★ Position spotlightLEGNLEGEND BIOTECH CORP · 20.8% of bookThis highlighted stock and its 1Y chart are public
Loading position history…
Security⇅Shares⇅Market Value▼Est. Cost⇅Last Px⇅Est. Return⇅% Portfolio⇅Δ Shares⇅Action⇅
LEGEND BIOTECH CORP
LEGN· Health Care
5.98MSH$172.8M~$28.88$20.94▼27.5%20.8%—Unchanged
FUTU HLDGS LTD
FUTU· Financials
1.77MSH$165.8M~$93.74$115.81▲23.5%19.9%▲ 24.6%Added
ARRIVENT BIOPHARMA INC
AVBP· Health Care
3.93MSH$136.5M~$34.74$28.26▼18.7%16.4%—Unchanged
MARVELL TECHNOLOGY INC
MRVL· Information Technology
163KSH$48.5M~$297.89$229.29▼23.0%5.8%▼ 4.7%Reduced
VIPSHOP HLDGS LTD
VIPS· Consumer Discretionary
3.47MSH$46.0M~$13.26$14.32▲8.0%5.5%▲ 2683.0%Added
PDD HOLDINGS INC
PDD· Consumer Discretionary
500KSH$38.1M~$76.28$87.07▲14.1%4.6%▼ 88.0%Reduced
KE HLDGS INC
BEKE· Real Estate
2.22MSH$32.2M~$14.53$17.71▲21.9%3.9%▼ 47.6%Reduced
CYTEK BIOSCIENCES INC
CTKB· Health Care
6.66MSH$29.5M~$4.43$4.44▲0.2%3.5%—Unchanged
ALAMAR BIOSCIENCES INC
ALMR
956KSH$25.9M~$27.09$32.70▲20.7%3.1%NewNew
ALIBABA GROUP HLDG LTD
BABA· Consumer Discretionary
184KSH$17.7M~$95.98$118.47▲23.4%2.1%▼ 92.5%Reduced
LEGNLEGEND BIOTECH CORPUnchanged
$172.8M· 20.8%· 5.98M SH· —· cost $28.88· last $20.94· ▼27.5%
Health Care · SPONSORED ADS · OTR
FUTUFUTU HLDGS LTDAdded
$165.8M· 19.9%· 1.77M SH· ▲ 24.6%· cost $93.74· last $115.81· ▲23.5%
Financials · SPON ADS CL A · OTR
AVBPARRIVENT BIOPHARMA INCUnchanged
$136.5M· 16.4%· 3.93M SH· —· cost $34.74· last $28.26· ▼18.7%
Health Care · COM · OTR
MRVLMARVELL TECHNOLOGY INCReduced
$48.5M· 5.8%· 163K SH· ▼ 4.7%· cost $297.89· last $229.29· ▼23.0%
Information Technology · COM · OTR
VIPSVIPSHOP HLDGS LTDAdded
$46.0M· 5.5%· 3.47M SH· ▲ 2683.0%· cost $13.26· last $14.32· ▲8.0%
Consumer Discretionary · SPONSORED ADS A · OTR
PDDPDD HOLDINGS INCReduced
$38.1M· 4.6%· 500K SH· ▼ 88.0%· cost $76.28· last $87.07· ▲14.1%
Consumer Discretionary · SPONSORED ADS · OTR
BEKEKE HLDGS INCReduced
$32.2M· 3.9%· 2.22M SH· ▼ 47.6%· cost $14.53· last $17.71· ▲21.9%
Real Estate · SPONSORED ADS · OTR
CTKBCYTEK BIOSCIENCES INCUnchanged
$29.5M· 3.5%· 6.66M SH· —· cost $4.43· last $4.44· ▲0.2%
Health Care · COM · OTR
ALMRALAMAR BIOSCIENCES INCNew
$25.9M· 3.1%· 956K SH· New· cost $27.09· last $32.70· ▲20.7%
COMMON STOCK · OTR
BABAALIBABA GROUP HLDG LTDReduced
$17.7M· 2.1%· 184K SH· ▼ 92.5%· cost $95.98· last $118.47· ▲23.4%
Consumer Discretionary · SPONSORED ADS · OTR
1–10 of 35
1 / 4
Sector Breakdown
Q2 2026
Health Care45.8% · $380.8M
Financials19.9% · $165.8M
Consumer Discretionary12.4% · $103.2M
Information Technology9.9% · $82.1M
Unclassified5.2% · $43.5M
Real Estate3.9% · $32.2M
Consumer Staples1.9% · $15.5M
Other1.1% · $9.0M
← All 13F filings